AIA
LLY icon

Allegis Investment Advisors’s Eli Lilly LLY Stock Holding History

Allegis Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,595
Closed -$214K – 269
2017
Q2 		$214K Sell
2,595
-264
-9% -$21.5K 0.05% 244
2017
Q1 		$240K Buy
+2,859
New +$229K 0.06% 222
2016
Q1 		– Sell
-1,882
Closed -$159K – 607
2015
Q4 		$159K Buy
+1,882
New +$156K 0.09% 171

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Allegis Investment Advisors's LLY Position: Q3 2017 in Review

Allegis Investment Advisors sold out of Eli Lilly (LLY) in Q3 2017, closing a stake of 2,595 shares — an estimated $214K sold.

Allegis Investment Advisors first reported a position in LLY in Q4 2015 and held it in 3 quarters. The position peaked at $240K in Q1 2017. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Allegis Investment Advisors reported no remaining Eli Lilly position as of Q3 2017 after selling out during the quarter.
  • Allegis Investment Advisors sold 2,595 Eli Lilly shares in Q3 2017, an estimated $214K.
  • Allegis Investment Advisors first reported a position in Eli Lilly in Q4 2015 and held it in 3 quarters.
  • Allegis Investment Advisors's Eli Lilly position peaked at $240K in Q1 2017.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Allegis Investment Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.